Get 20% lifetime commission for referring investors to digrin.com
here.
Prelude Therapeutics Incorporated ( PRLD) - Stock Earnings
PRLD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
PRLD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -16.5 million USD | 5.6 million USD |
| 2026Q1 | -10.4 million USD | 4.6 million USD |
| 2026Q2 | -13.9 million USD | 5.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PRLD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -121.8 million USD | — USD |
| 2024 | -127.2 million USD | 7.0 million USD |
| 2025 | -99.5 million USD | 12.1 million USD |
| 2026 Est. | — | — |
PRLD
Price: $3.26
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65500
Market Capitalization: 214.6 million